Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 5 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 7 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 6 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 2 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 5 days agoNovavax and Inovio have soared since 2024 started. Which of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 7 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Shah Capital ends campaign against Novavax board after Sanofi deal
WSAU Wausau· 7 days ago(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 3 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 3 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 7 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...